Industry Developments
GlaxoSmithKline (GSK) is a leading global manufacturer of prescription medicines and consumer healthcare products. The company has offices in over 100 countries and major research centres...
2013-05-02Italy
BMI View: Governments across Europe are focussing on cost containment. The consequent scrutiny on drug prices and medicine consumption will subsequently put pressure on companies and...
2013-02-22Switzerland
BMI View: Novartis' U-turn over CEO Daniel Vasella's exit package could fuel support for a March 3 2013 referendum in Switzerland that proposes changes to Swiss corporate laws, including...
2013-02-20Denmark
BMI View: The FDA rejection of Tresiba and Ryzodeg has led to a significant revision of earnings expectations for the market. Novo Nordisk's share price tumbled after February 12th....
2013-02-19United Kingdom
BMI View: While the increase in GP and pharmacy services translates into Sainsbury's recognition of the medical services sector as a profitable avenue down which to direct its expansion...
2013-02-18Germany
BMI View: Declining pharmacy numbers in Germany reveal that the effects of the government's cost-containment measures are not confined to drugmakers. Pharmacies are contributors to...
2013-02-12United Kingdom
BMI View: While it is difficult to gauge the precise amount drugmakers spend on marketing activities, it is clear that drug companies' marketing budgets are worth...
2013-02-07Finland
BMI View: While Finland's pharmaceutical market is small compared with its Western European neighbours, BMI believes the country's high public expenditure on health and its favourable...
2013-02-05
